- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06934746
Evaluation of Screen Time and Digital Media on ADHD (ADHD)
April 12, 2025 updated by: Janice Gamil Sadek Zakka, Assiut University
- Assess how different types of digital media influence inattention, impulsivity, and hyperactivity in children with ADHD.
- Analyze the role of screen time duration, content type, parental supervision, and socioeconomic status in ADHD symptom severity.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental disorders in children, characterized by persistent patterns of inattention, hyperactivity, and impulsivity.
Studies suggest that its prevalence has risen due to improved recognition and changing diagnostic criteria.
Children with ADHD experience significant challenges in school performance, including difficulty sustaining attention, frequent careless mistakes, and trouble following instructions, all of which contribute to lower academic achievement and increased need for special education support.
ADHD is linked to problematic eating behaviors, as irregular meal patterns, increased consumption of unhealthy foods, and a higher risk of obesity due to impulsivity and poor self-regulation.
Beyond academics and nutrition, ADHD also affects sleep quality, emotional regulation, and social interactions, leading to increased behavioral issues and conflicts with peers and family members.
The widespread use of digital media further complicates these challenges, as excessive screen time has been associated with exacerbating ADHD symptoms and negatively impacting cognitive and emotional development.
These findings highlight the urgent need for targeted interventions to support children with ADHD across multiple aspects of their daily lives
Study Type
Observational
Enrollment (Estimated)
130
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Janice Gamil Sadek, MD
- Phone Number: 01288823678
- Email: Janes.14224026@med.aun.edu.eg
Study Contact Backup
- Name: Emad ElDeen Mahmoud Hammad, Professor
- Phone Number: 01223559943
- Email: emadhammad@aun.edu.eg
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Neuro-psychiatric Outpatient clinic in Assiut University Children Hospita
Description
Inclusion Criteria:
- Diagnosed children with ADHD, confirmed by DSM-5 and Gilliam ADHD rating scale. • Parental consent for participation.
Exclusion Criteria:
- Comorbid neurodevelopmental disorders (e.g., autism, intellectual disability). • Chronic medical conditions affecting cognitive or behavioral function.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Inattention Symptoms Measured by the ADHD Rating Scale-IV
Time Frame: Baseline (Day 1) and after 6 months of follow-up
|
Evaluate the change in inattention symptoms before and after exposure to different types of digital media (e.g., videos, games, educational apps) using the ADHD Rating Scale-IV completed by parents or caregivers.
|
Baseline (Day 1) and after 6 months of follow-up
|
|
Change in Hyperactivity/Impulsivity Symptoms Measured by the ADHD Rating Scale-IV
Time Frame: Baseline (Day 1) and after 6 months of follow-up
|
Assess the change in hyperactivity and impulsivity symptoms in children with ADHD in relation to total daily screen time, content type, and level of parental supervision, using the ADHD Rating Scale-IV.
|
Baseline (Day 1) and after 6 months of follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between Socioeconomic Status and ADHD Symptom Severity
Time Frame: After 6 months of follow-up
|
Analyze the association between family socioeconomic status (SES) and the severity of ADHD symptoms after 6 months of exposure to digital media, using standardized SES assessment tools and ADHD Rating Scale-IV scores.
|
After 6 months of follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
April 6, 2025
First Submitted That Met QC Criteria
April 12, 2025
First Posted (Actual)
April 18, 2025
Study Record Updates
Last Update Posted (Actual)
April 18, 2025
Last Update Submitted That Met QC Criteria
April 12, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- role of digital media in ADHD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Monitor Adverse Events
-
University of PennsylvaniaTerminatedAdverse Events | SEDLine | Accoustic Respiratory Monitor RAD87 | Advanced Endoscopic ProceduresUnited States
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningMonitor Adverse EventsUnited States
-
Irrimax CorporationCompleted
-
University of AlbertaCompleted
-
Qinghai Red Cross HospitalNot yet recruitingCancer | Adverse EventsChina
-
AstraZenecaCompletedAdverse Events | PharmacokineticUnited States
-
Zhong WangShanxi Zhendong Pharmacy Co., LtdRecruitingAdverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse ReactionsChina
-
Sichuan Provincial People's HospitalRecruitingPerioperative Respiratory Adverse EventsChina
-
AstraZenecaCompletedAdverse Events | Pharmacokinetic VariablesUnited States
-
Zhong WangShanxi Zhendong pharmaceutical Co. LTD.CompletedAdverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse ReactionsChina
Clinical Trials on DSM-5 criteria.
-
Ankara Ataturk Sanatorium Training and Research...RecruitingHip Fracture | Postoperative Delirium (POD) | CRP | Lymphocyte | AlbuminTurkey
-
Centre Hospitalier de NiortCompleted
-
Aydin Adnan Menderes UniversityNot yet recruitingDelirium | Validity
-
University of Milano BicoccaUniversity of MilanCompletedGeneralized Anxiety Disorder | Panic Disorder | Duration of Untreated IllnessItaly
-
Parnassia GroepRecruiting
-
Senseye, Inc.CompletedPTSD | Generalized Anxiety Disorder | Major Depressive DisorderUnited States
-
Tanta UniversityCompleted
-
Senseye, Inc.Lindus Health; Medtryx Pty LtdRecruitingPTSD - Post Traumatic Stress DisorderUnited States, Australia
-
Children's Memorial Health Institute, PolandUnknown